ArticleScientific reports2025
Development and validation of the airway surgery enclosure for high-risk aerosol-generating airway procedures: a bench and clinical study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Procedures on the upper airway in patients with respiratory viruses are considered to carry the greatest risk of infection spread to operating room personnel through aerosolization. Appropriate personal protective equipment must be worn, but availability varies worldwide and resources may be limited. We describe the development, validation, and safe implementation of a reusable enclosure with an inexpensive, acrylic design, for use in high-risk airway procedures. Examples of common yet high-risk, aerosol-generating procedures performed with the Airway Surgery Enclosure (ASE) include laryngo-bronchoscopy, suspension laryngoscopy for removal of airway lesions, and rigid bronchoscopy including airway foreign body removal. The ASE demonstrated an 87-94% reduction in aerosolized particle concentration compared to ambient room levels. Bench testing validated the containment capability through laser-based particle imaging and air sampling, while clinical evaluations confirmed ergonomic feasibility and usability. While the ASE provides significant reductions in aerosol exposure, implementation challenges include integration with existing operating room workflows, material durability over repeated sterilization cycles, and cost considerations for widespread adoption. Further studies are needed to assess long-term clinical effectiveness and user adaptability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.